The validity of change of SOFA on day 7 as an early predictor of 28-day mortality was analyzed in a large post-marketing survey among patients with sepsis and disseminated intravascular coagulation, who were propensity-matched to receive either antithrombin III alone or combination therapy with thrombomodulin. Here, THBD is linked to Disseminated intravascular coagulation.